Mutated br2 protein and application thereof
By introducing mutant br2 protein into corn, the problems of lack of breeding resources and insufficient lodging resistance are solved, and the reduction of plant height and ear height are achieved, and the yield increase under high-density planting conditions is provided, providing better breeding Resources and resistance to lodging.
Patent Information
- Application Number
- CN202411068289.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2023-11-22
- Filing Date
- 2024-08-06
- Publication Date
- 2024-11-22
AI Technical Summary
In the prior art, the germplasm resources used for plant height reduction in corn breeding are limited, which leads to narrowing of corn breeding resources and hinders the process of breeding excellent corn varieties. At the same time, the corn has insufficient lodging resistance under high-density planting conditions.
The mutated br2 protein was introduced into corn through gene editing technology, and specifically through gene editing in the CDS sequence and 3'UTR sequence of the br2 protein, resulting in a decrease in plant height and ear height, improving anti-lostment ability and yield, and improving in high density Yield under planting conditions.
The corn plant height and ear height have been achieved, the lodging resistance and yield have been improved, the lodging resistance and dense planting ability under high-density planting conditions has been enhanced, and more breeding resources have been provided.
Smart Images

Figure CN118994344A_ABST
Abstract
Description
[0001] This application claims the priority of Chinese patent application CN202311559090.3, filed on November 22, 2023. This application cites the full text of the above Chinese patent application. Technical Field
[0002] The invention belongs to the fields of biotechnology and crop genetic breeding, and relates to a mutant br2 protein and an application thereof, in particular to a mutant br2 protein in corn and an application thereof in reducing corn plant height and ear height and improving corn lodging resistance. Background Art
[0003] Corn is the crop with the largest planting area in the world, with an annual global planting area of more than 2 billion mu and a total output of 1 billion tons. Its edible value, industrial value and feed value make it an important part of my country's food security system. At present, the increase in corn yield is due to the increase in planting density. Under high-density conditions, plants produce shade avoidance reactions, which are manifested in changes in traits such as increased plant height and ear height, thinner stems, reduced stem-leaf angles, slender leaves, abnormal male and female development, and increased male-female intervals. Ultimately, it is manifested in reduced lodging resistance, reduced photosynthetic efficiency, reduced seed setting rate, and reduced single-plant yield. Varieties with compact plant types and low plant heights generally show strong density tolerance. Reducing plant height often makes the stems thicker, especially reducing the ear position, which is more conducive to increasing the plant's lodging resistance. In addition, appropriately reducing plant height and ear height can also increase the harvest index of corn. Therefore, dwarfing breeding under the premise of maintaining yield is an important direction of current corn breeding.
[0004] Although there are many studies on plant height, and plant hormones such as auxin, gibberellin, brassinolide, and cytokinin can regulate plant height, the germplasm resources in corn that can be used for dwarfing plant height improvement are limited. Using limited dwarfing germplasm resources to improve plant height through traditional breeding methods will make the already scarce corn breeding germplasm resources even narrower, hindering the breeding of more excellent corn varieties.
[0005] Through gene editing technology, various types of dwarf mutants have been created in maize inbred lines by knocking out single genes, changing the amino acid sequence of genes, and changing the amount of gene expression, which can achieve different degrees of plant height reduction. Moreover, some mutations show that the reduction in ear height is greater than the reduction in plant height. This mutation, which mainly reduces the length of the internodes below the ear, is more conducive to the breeding of maize that is resistant to lodging and tolerant to dense planting. Summary of the invention
[0006] The invention provides a mutant br2 protein and application of the mutant protein in reducing corn plant height and ear height, improving corn lodging resistance, increasing corn yield and increasing corn yield under high-density planting conditions.
[0007] On the one hand, the present invention provides a br2 mutant protein, wherein the CDS sequence and 3'UTR sequence of the mutant br2 protein have base deletions relative to the CDS sequence and 3'UTR sequence of the parent br2 protein, and the parent br2 protein is derived from corn; the mutant br2 protein causes the plant height and / or ear height of corn to be reduced, the lodging resistance to be improved, the yield to be increased, and the yield to be increased under high-density planting conditions.
[0008] In one embodiment, the CDS sequence of the mutated br2 protein lacks bases 4102-4137 corresponding to the sequence shown in SEQ ID No.1 relative to the CDS sequence of the parent br2 protein; the 3'UTR sequence of the mutated br2 protein lacks bases 1-36 and bases 160-162 corresponding to the sequence shown in SEQ ID No.2 relative to the 3'UTR sequence of the parent br2 protein.
[0009] In one embodiment, the parent br2 protein is derived from a naturally occurring corn strain (e.g., a naturally occurring corn inbred line), and the CDS sequence of the parent br2 protein has at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% sequence identity with the sequence shown in SEQ ID No.1; the 3'UTR sequence of the parent br2 protein has at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% sequence identity with the sequence shown in SEQ ID No.2.
[0010] In one embodiment, the parent br2 protein is derived from a maize inbred line.
[0011] In one embodiment, the parent br2 protein is derived from the maize inbred line PH4CV.
[0012] In one embodiment, the corn is the corn inbred line PH4CV.
[0013] In one embodiment, the CDS sequence of the parent br2 protein is shown as SEQ ID No.1.
[0014] In one embodiment, the 3'UTR sequence of the parent br2 protein is as shown in SEQ ID No.2.
[0015] In one embodiment, the amino acid sequence of the parent br2 protein is shown in SEQ ID No.3.
[0016] In one embodiment, the CDS sequence of the mutated br2 protein is shown as SEQ ID No.5.
[0017] In one embodiment, the 3'UTR sequence of the mutant br2 protein is shown as SEQ ID No.6.
[0018] On the other hand, a fusion protein is provided, comprising the mutant protein or its biologically active fragment as described above; further, the fusion protein also comprises a protein fused with the mutant protein, for example, a tag peptide, a plastid guiding peptide or a regulatory element. Among them, the tag peptide is, for example, a histidine tag, 6×His; the plastid guiding peptide is, for example, a peptide guiding into the chloroplast; the regulatory element is, for example, a promoter sequence, a terminator sequence, a leader sequence, a polyadenylation sequence, a marker gene, etc.
[0019] On the other hand, the present invention provides a polynucleotide encoding the br2 mutant protein or fusion protein.
[0020] In another preferred embodiment, the polynucleotide is selected from the following group: genomic sequence, cDNA sequence, RNA sequence, or a combination thereof.
[0021] In another preferred embodiment, the polynucleotide is preferably single-stranded or double-stranded.
[0022] In another preferred embodiment, the polynucleotide further contains auxiliary elements selected from the following groups on the flank of the ORF of the mutant polypeptide: a signal peptide, a secretory peptide, a tag sequence (such as 6His), a nuclear localization signal or a combination thereof.
[0023] In another preferred example, the polynucleotide further comprises a promoter operably linked to the ORF sequence of the mutant polypeptide.
[0024] In another preferred embodiment, the promoter is selected from the following group: a constitutive promoter, a tissue-specific promoter, an inducible promoter, or a strong promoter.
[0025] In another aspect, the present invention provides a nucleic acid construct comprising the polynucleotide and a regulatory element operably linked thereto.
[0026] In another preferred embodiment, the regulatory element is selected from one or more of the following groups: enhancer, transposon, promoter, terminator, leader sequence, polyadenylation sequence, marker gene.
[0027] On the other hand, the present invention also provides a vector, which contains a nucleic acid sequence encoding the br2 mutant protein of the present invention or the above-mentioned polynucleotide. Preferably, the vector also includes an expression regulatory element operably connected to the above-mentioned nucleic acid sequence.
[0028] In another preferred embodiment, the vector includes a cloning vector, an expression vector, a shuttle vector or an integration vector.
[0029] In one embodiment, the vector may be a vector for gene editing the CDS sequence and / or 3'UTR sequence of the endogenous br2 protein of the host cell.
[0030] In one embodiment, the expression vector also contains at least one replication origin to achieve self-replication.
[0031] In one embodiment, the vector may be one which, when introduced into the host cell, is integrated into the genome and replicated together with the chromosome into which it has been integrated.
[0032] The vector can be of the type of plasmid, virus, cosmid, phage, etc., which are well known to those skilled in the art.
[0033] Preferably, the vector in the present invention is a plasmid.
[0034] In another aspect, the present invention provides a host cell, wherein the host cell contains one or more of the br2 mutant protein, the encoding gene, the fusion protein, the polynucleotide, the nucleic acid construct, and the vector; or, the polynucleotide is integrated into the genome of the host cell.
[0035] In another preferred embodiment, the host cell is a eukaryotic cell, such as a yeast cell, an animal cell or a plant cell.
[0036] In another preferred embodiment, the host cell is a prokaryotic cell, such as Escherichia coli.
[0037] In another preferred example, the plants include angiosperms and gymnosperms.
[0038] In another preferred example, the plants include monocotyledonous plants and dicotyledonous plants.
[0039] In another preferred embodiment, the plants include herbaceous plants and woody plants.
[0040] In another preferred embodiment, the plants include Arabidopsis, tobacco, rice, corn, sorghum, barley, wheat, millet, soybean, tomato, potato, quinoa, lettuce, rapeseed, cabbage, and strawberry.
[0041] On the other hand, the present invention provides an editing vector system, the editing vector system comprises one or more vectors, the one or more vectors at least comprising a guide sequence targeting the 3'UTR sequence of the parent br2 protein. The guide sequence contains a nucleotide sequence of the 3'UTR sequence of a part of the parent br2 protein, preferably a nucleotide sequence of the 3'UTR sequence of the br2 protein of at least 15bp, and more preferably a nucleotide sequence of the 3'UTR sequence of the br2 protein of at least 20bp. In one embodiment, the editing vector system also includes a gene editing enzyme. The gene editing enzyme includes nucleases of CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats), TALEN (Tanscription Activator-like (TAL) effector nucleases), and ZFN (Zinc finger nuclease) editing tools.
[0042] Preferably, the gene editing enzyme is a Cas protein, also known as CRISPR enzyme or Cas effector protein, and its types include but are not limited to: Cas9 protein, Cas12 protein, Cas13 protein, Cas14 protein, Csm1 protein, FDK1 protein.
[0043] Preferably, the Cas protein is operably linked to a first regulatory element.
[0044] In one embodiment, the gene editing enzyme is a Cas9 protein, and the vector further includes a Scaffold sequence that can specifically bind to the Cas9 protein. After the Scaffold sequence is operably connected to the guide sequence, it constitutes a guide guide sequence (gRNA). Preferably, the gRNA is operably connected to the second regulatory element.
[0045] In other embodiments, the gene editing enzyme is a Cas12 protein, for example, Cas12a, Cas12b, Cas12i, Cas12i mutant protein, and the vector also includes a unidirectional repeat sequence (Direct Repeat) that specifically binds to the Cas12 protein. After the unidirectional repeat sequence is operably connected to the guide sequence, a guide guide sequence (gRNA) is formed. Preferably, the gRNA is operably connected to the second regulatory element.
[0046] In other embodiments, the gene editing enzyme is a Cas12i mutant protein, and the amino acid sequence of the wild-type Cas12i is shown in SEQ ID No.4; compared with SEQ ID No.4, the Cas12i mutant protein has the S at position 7 mutated to R, the D at position 233 mutated to R, the D at position 267 mutated to R, the N at position 369 mutated to R, and the S at position 433 mutated to R.
[0047] Such regulatory elements include promoters, terminator sequences, leader sequences, polyadenylation sequences, signal peptide coding regions, marker genes, enhancers, internal ribosome entry sites (IRES), and other expression control elements (e.g., transcription termination signals, such as polyadenylation signals and poly-U sequences).
[0048] Preferably, the editing vector system further comprises a base editing element, and the base editing element is selected from adenine deaminase and / or cytosine deaminase.
[0049] In one embodiment, the editing vector also contains resistance genes for easy screening, and the resistance genes include hyg, bar, kana, rif, spec, and amp. The resistance genes are well known to those skilled in the art.
[0050] Preferably, the Cas protein is nCas9 or other Cas9 proteins with nick activity, wherein "n" represents nick, i.e., a Cas protein with only single-strand cleavage activity.
[0051] On the other hand, the present invention provides a gene editing reagent, which can produce the above-mentioned mutant polypeptide in plants; the gene editing reagent includes CRISPR / Cas protein and gRNA, and the gRNA can target the CDS sequence and 3'UTR sequence of the plant endogenous br2 protein; optionally, the gene editing reagent also includes a base editing element, and the base editing element is selected from adenine deaminase and / or cytosine deaminase.
[0052] In another embodiment, the gene editing reagent includes the above-mentioned editing vector system.
[0053] On the other hand, the present invention provides a method for reducing plant height and / or ear height, improving plant lodging resistance, increasing plant yield or increasing plant yield under high-density planting conditions, or a method for preparing plants with reduced plant height and / or ear height, improved lodging resistance, increased yield or increased yield under high-density planting conditions, the method comprising the steps of introducing the above-mentioned br2 mutant protein into plant cells, plant seeds, plant tissues, plant parts or plants, and the plant is corn.
[0054] On the other hand, the present invention provides a method for improving plant traits, which comprises the step of introducing the above-mentioned br2 mutant protein into plant cells, plant seeds, plant tissues, plant parts or plants, wherein the plant is corn.
[0055] In one embodiment, the improved plant traits include reducing plant height and / or ear height, improving plant lodging resistance, increasing plant yield, or increasing plant yield under high-density planting conditions.
[0056] In one embodiment, the introduction of the br2 mutant protein includes the step of expressing the br2 mutant protein in plant cells, plant tissues, plant parts or plants, for example, expressing the mutant protein through an expression vector, or integrating the polynucleotide encoding the mutant protein into the plant genome for expression.
[0057] In another preferred embodiment, the introduction of the br2 mutant protein comprises the step of mutating the CDS sequence and 3'UTR sequence of the endogenous br2 protein of the plant to thereby introduce the mutant protein.
[0058] In another preferred embodiment, the introduction of the br2 mutant protein comprises the steps of mutating the CDS sequence and 3'UTR sequence of the plant's endogenous br2 protein and expressing the mutant protein to introduce the mutant protein.
[0059] In another preferred embodiment, in the described method, the method of introducing mutations includes natural variation, physical mutagenesis (such as ultraviolet mutagenesis, X-ray or Y-ray mutagenesis), chemical mutagenesis (such as nitrite, hydroxylamine, EMS, nitrosoguanidine, etc.), biological mutagenesis (such as virus or bacteria-mediated mutagenesis), and gene editing.
[0060] In another preferred embodiment, the method comprises the following steps:
[0061] (1) Introducing expression vectors containing gene editing tools into plant cells, plant tissues, or plant parts;
[0062] (2) allowing the gene editing tool to act on the 3'UTR sequence of its endogenous br2 protein and causing mutations at the above mutation sites corresponding to SEQ ID No. 1 and SEQ ID No. 2;
[0063] (3) Screening for mutant plant cells, plant tissues, and plant parts;
[0064] (4) Isolating the gene editing tool.
[0065] In another preferred embodiment, the gene editing tools include CRISPR, TALEN and ZFN.
[0066] On the other hand, the present invention also provides the use of the above-mentioned br2 mutant protein, polynucleotide, vector, nucleic acid construct, gene editing reagent or host cell in preparing plants with reduced plant height and / or ear height, improved lodging resistance, increased yield or increased yield under high-density planting conditions, wherein the plant is corn; or, in preparing reagents or kits for reducing plant height and / or ear height, improving plant lodging resistance, increasing plant yield or increasing plant yield under high-density planting conditions.
[0067] The present invention also provides a corn plant with reduced plant height and / or ear height, improved lodging resistance, increased yield or increased yield under high-density planting conditions, wherein the corn plant contains the above-mentioned br2 mutant protein, polynucleotide, vector, gene editing reagent or host cell.
[0068] The reducing of plant height and / or ear height, or the reducing of plant height and / or ear height, means that the plant height and / or ear height of a corn plant containing the above-mentioned br2 mutant protein, nucleic acid, nucleic acid construct, vector, gene editing reagent or host cell is lower than the plant height and / or ear height of a corn plant containing the parent br2 protein.
[0069] The plant height refers to the height from the ground to the highest point of the corn.
[0070] In one embodiment, the height of corn plants containing the br2 mutant protein of the present invention is reduced by about 10%-90% compared to the wild type, for example, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 55%, 60%, 65%, 70%, 75%, 80%, 85%.
[0071] The improved lodging resistance of plants, or the improved lodging resistance, means that the lodging resistance of corn plants containing the above-mentioned br2 mutant protein, nucleic acid, nucleic acid construct, vector, gene editing reagent or host cell is stronger than the lodging resistance of corn plants containing the parent br2 protein.
[0072] The increasing of plant yield, or yield improvement, means that the yield of corn plants containing the above-mentioned br2 mutant protein, nucleic acid, nucleic acid construct, vector, gene editing reagent or host cell is higher than the yield of corn plants containing the parent br2 protein.
[0073] The increasing of plant yield under high-density planting conditions, or increasing of yield under high-density planting conditions, means that the yield of corn plants containing the above-mentioned br2 mutant protein, nucleic acid, nucleic acid construct, vector, gene editing reagent or host cell under high-density planting conditions is higher than the yield of corn plants containing the parent br2 protein under high-density planting conditions.
[0074] The high-density planting refers to the number of plants planted per unit area of land being higher than the optimum planting density, the guiding planting density, the conventional planting density or the ordinary planting density. For example, in the Huanghuai region, the ordinary planting density of corn is about 4,500 plants per mu, and the ordinary planting density of a few corn varieties reaches 5,000 plants per mu. In one embodiment, the high-density planting condition refers to a corn planting density exceeding 4,500 plants per mu; preferably, exceeding 5,000 plants per mu; more preferably, exceeding 5,500 plants per mu.
[0075] The present invention also provides a method for reducing plant height and / or ear height, improving plant lodging resistance, increasing plant yield or increasing plant yield under high-density planting conditions, or a method for preparing plants with reduced plant height and / or ear height, improved lodging resistance, increased yield or increased yield under high-density planting conditions, the method comprising the step of using the above-mentioned gene editing reagent to perform gene editing on the endogenous br2 protein CDS sequence and 3'UTR sequence of the plant, wherein the plant is corn.
[0076] In another aspect, the present invention provides a reagent or a kit, which can be used to reduce the plant height and / or ear height of a plant, improve the lodging resistance of a plant, increase the yield of a plant, or increase the yield of a plant under high-density planting conditions. The reagent contains the mutant protein, a polynucleotide encoding the mutant protein, a vector, a nucleic acid construct, a gene editing reagent or a host cell according to the present invention.
[0077] Unless defined otherwise, technical and scientific terms used herein have the same meanings as commonly understood by one of ordinary skill in the art.
[0078] The term "vector" is a vector that contains elements that allow the vector to be integrated into the host cell genome or to replicate autonomously in the cell independently of the genome. The vector may contain any element that ensures self-replication. It usually carries genes that are not part of the central metabolism of the cell and is usually in the form of double-stranded DNA. The choice of vector usually depends on the compatibility of the vector with the host cell into which the vector is to be introduced. If a vector is used, the choice of vector depends on methods well known to those skilled in the art for transforming host cells. For example, a plasmid vector can be used.
[0079] The term "3'UTR" refers to the 3' untranslated region or 3' non-coding region of the br2 gene (Brachytic2) in corn, and the term "parental 3'UTR" refers to the sequence from which the mutated 3'UTR sequence is derived. In a preferred embodiment, the parental 3'UTR is a 3'UTR nucleic acid molecule of the br2 gene that can be found in nature in corn, and its nucleotides can be obtained by genetic engineering techniques, such as genome sequencing, polymerase chain reaction (PCR), etc.
[0080] As used herein, the term "identity" is used to refer to the matching of sequences between two polypeptides or between two nucleic acids. When a position in both sequences being compared is occupied by the same base or amino acid monomer subunit (e.g., a position in each of the two DNA molecules is occupied by adenine, or a position in each of the two polypeptides is occupied by lysine), then the molecules are identical at that position. The "percent identity" between two sequences is a function of the number of matching positions shared by the two sequences divided by the number of positions compared x 100. For example, if 6 out of 10 positions in two sequences match, then the two sequences have 60% identity. For example, the DNA sequences CTGACT and CAGGTT share 50% identity (3 out of a total of 6 positions match). Typically, the comparison is made when the two sequences are aligned to produce maximum identity. Such an alignment can be achieved by using, for example, the method of Needleman et al. (1970) J. Mol. Biol. 48: 443-453, which can be conveniently performed by a computer program such as the Align program (DNAstar, Inc.). The percent identity between two amino acid sequences can also be determined using the algorithm of E. Meyers and W. Miller (Comput. Appl Biosci., 4: 11-17 (1988)), which has been incorporated into the ALIGN program (version 2.0), using a PAM120 weight residue table, a gap length penalty of 12, and a gap penalty of 4. In addition, the percent identity between two amino acid sequences can be determined using the Needleman and Wunsch (J Mol. Biol. 48: 444-453 (1970)) algorithm, which has been incorporated into the GAP program in the GCG software package (available at www.gcg.com), using a Blossum 62 matrix or a PAM250 matrix and a gap weight of 16, 14, 12, 10, 8, 6, or 4 and a length weight of 1, 2, 3, 4, 5, or 6.
[0081] "Homology" or "identity" can be calculated by known methods including, but not limited to, Computational Molecular Biology (Lesk, AM, ed.) Oxford University Press, New York (1988); Biocomputing: Informatics and Genome Projects (Smith, DW, ed.) Academic Press, New York (1993); Computer Analysis of Sequence Data, Part I (Griffin, AM and Griffin, HG, eds.) Humana Press, New Jersey (1994); Sequence Analysis in Molecular Biology (von Heinje, G., ed.) Academic Press (1987); and Sequence Analysis Primer (Gribskov, M. and Devereux, J., eds.) Stockton, New Jersey (1993). Stockton Press, New York (1991).
[0082] The specific amino acid positions (numbers) of the br2 proteins of the present invention are determined by aligning the target amino acid sequences using standard sequence alignment tools, such as using the Smith-Waterman algorithm or using the CLUSTALW2 algorithm to align two sequences, wherein the sequences are considered aligned when the alignment score is the highest. The alignment score can be calculated according to the method described in Wilbur, WJ and Lipman, DJ (1983) Rapid similarity searches of nucleic acid and protein data banks. Proc. Natl. Acad. Sci. USA, 80: 726-730. The default parameters are preferably used in the ClustalW2 (1.82) algorithm: protein gap open penalty = 10.0; protein gap extension penalty = 0.2; protein matrix = Gonnet; protein / DNA end gap = -1; protein / DNAGAPDIST = 4. Preferably, the AlignX program (part of the vectorNTI group) is used with default parameters suitable for multiple alignment (gap opening penalty: 10og gap extension penalty 0.05). By comparing the amino acid sequences of br2 proteins of different maize inbred lines or varieties, the specific positions corresponding to the amino acids of the br2 proteins of different parents and SEQ ID No.3 are determined; by sequence alignment methods known in the art, those skilled in the art can obtain the amino acid correspondence between the br2 protein sequences of different varieties of maize and SEQ ID No.3.
[0083] The specific nucleotide (base) position (number) within the 3'UTR of the present invention is determined by aligning the target nucleotide using a standard sequence alignment tool, such as using the Smith-Waterman algorithm or using the CLUSTALW2 algorithm to align two sequences, wherein the sequences are considered aligned when the alignment score is the highest. The alignment score can be calculated according to the method described in Wilbur, WJ and Lipman, DJ (1983) Rapid similarity searches of nucleic acid and protein data banks. Proc. Natl. Acad. Sci. USA, 80: 726-730. The default parameters are preferably used in the ClustalW2 (1.82) algorithm: protein gap open penalty = 10.0; protein gap extension penalty = 0.2; protein matrix = Gonnet; protein / DNA end gap = -1; protein / DNAGAPDIST = 4. Preferably, the AlignX program (part of the vectorNTI group) is used with default parameters suitable for multiple alignment (gap opening penalty: 10og gap extension penalty 0.05). The specific positions of the 3'UTRs of different parents are determined by comparing the 3' untranslated region or 3' non-coding region (3'UTR) sequence of the br2 gene (Brachytic2) of different maize inbred lines or varieties with SEQ ID No.2 (the 3'UTR sequence of the br2 gene of the maize inbred line PH4CV). Through sequence alignment methods known in the art, those skilled in the art can obtain the base correspondence between the 3'UTR sequence of the br2 gene of different varieties of maize and SEQ ID No.2.
[0084] The term "plant tissue" or "plant part" includes plant cells, protoplasts, plant tissue cultures, plant callus, plant pieces, and plant embryos, pollen, ovules, seeds, leaves, stems, flowers, branches, seedlings, fruits, kernels, ears, roots, root tips, anthers, etc.
[0085] The term "plant cell" is to be understood as any cell from or found in a plant, which is capable of forming, for example: undifferentiated tissue such as callus, differentiated tissue such as embryos, plant components, plants or seeds.
[0086] The term "gene editing" technology includes CRISPR technology, TALEN technology, and ZFN technology. CRISPR technology refers to clustered, regularly interspaced short palindromic repeats, which come from the immune system of microorganisms. Among them, gene editing tools include guideRNA, Cas proteins (such as Cas9, Cpf1, Cas12b, etc.). The gene editing tool referred to in TALEN technology is a restriction enzyme that can cut a specific DNA sequence, which includes a TAL effector DNA binding domain and a DNA cleavage domain. The gene editing tool referred to in ZFN technology is also a restriction enzyme that can cut a specific DNA sequence, which includes a zinc finger DNA binding domain and a DNA cleavage domain. It is well known to those skilled in the art that the nucleotides encoding the gene editing tool and other regulatory elements are constructed in a suitable vector, and then the cell is transformed to achieve the editing of the genome in the cell. The types of editing include gene knockout, insertion, and base editing.
[0087] It is clear to those skilled in the art that the structure of a protein can be changed without adversely affecting its activity and functionality, for example, one or more conservative amino acid substitutions can be introduced into the amino acid sequence of a protein without adversely affecting the activity and / or three-dimensional structure of the protein molecule. Examples and embodiments of conservative amino acid substitutions are clear to those skilled in the art. Specifically, the amino acid residue can be replaced with another amino acid residue belonging to the same group as the site to be replaced, that is, a non-polar amino acid residue can be substituted for another non-polar amino acid residue, a polar uncharged amino acid residue can be substituted for another polar uncharged amino acid residue, a basic amino acid residue can be substituted for another basic amino acid residue, and an acidic amino acid residue can be substituted for another acidic amino acid residue. Such substituted amino acid residues may or may not be encoded by the genetic code. As long as the substitution does not result in the inactivation of the biological activity of the protein, a conservative substitution in which an amino acid is replaced by other amino acids belonging to the same group falls within the scope of the present invention. Therefore, the protein of the present invention may contain one or more conservative substitutions in the amino acid sequence, and these conservative substitutions are preferably generated by substitution according to Table 1. In addition, the present invention also covers proteins that also contain one or more other non-conservative substitutions, as long as the non-conservative substitutions do not significantly affect the desired function and biological activity of the protein of the present invention. Conservative amino acid substitutions can be carried out at one or more predicted non-essential amino acid residues. "Non-essential" amino acid residues are amino acid residues that can be changed (deleted, substituted or replaced) without changing biological activity, while "essential" amino acid residues are required for biological activity."Conservative amino acid substitutions" are substitutions in which amino acid residues are replaced by amino acid residues with similar side chains. Amino acid substitutions can be carried out in the non-conserved regions of br2 protein. Generally speaking, such substitutions are not carried out to conserved amino acid residues, or are not carried out to amino acid residues located in conserved motifs, where such residues are required for protein activity. However, it will be appreciated by those skilled in the art that functional variants can have less conservative or non-conservative changes in conserved regions.
[0088] It is well known in the art that one or more amino acid residues can be altered (replaced, deleted, truncated or inserted) from the N and / or C termini of a protein while still retaining its functional activity. Therefore, proteins in which one or more amino acid residues are altered from the N and / or C termini of the br2 protein while retaining its desired functional activity are also within the scope of the present invention. These alterations may include alterations introduced by modern molecular methods such as PCR, which includes PCR amplification of protein coding sequences by means of including amino acid coding sequences in oligonucleotides used in PCR amplification to alter or extend protein coding sequences.
[0089] It should be appreciated that proteins can be altered in various ways, including amino acid substitutions, deletions, truncations and insertions, and methods for such manipulations are generally known in the art. For example, amino acid sequence variants of br2 proteins can be prepared by mutations in DNA. Other forms of mutagenesis and / or orthogenesis can also be accomplished, for example, using known mutagenesis, recombination and / or shuffling methods, in conjunction with related screening methods, to perform single or multiple amino acid substitutions, deletions and / or insertions.
[0090] Those skilled in the art will appreciate that these minor amino acid changes in the br2 protein of the present invention can occur (e.g., naturally occurring mutations) or be produced (e.g., using r-DNA technology) without loss of protein function or activity. If these mutations occur in the catalytic domain, active site, or other functional domain of the protein, the properties of the polypeptide may be changed, but the polypeptide may retain its activity. If the mutations present are not close to the catalytic domain, active site, or other functional domain, lesser effects may be expected.
[0091] Those skilled in the art can identify the essential amino acids of br2 protein according to methods known in the art, such as site-directed mutagenesis or protein evolution or analysis of bioinformatics systems. The catalytic domain, active site or other functional domains of the protein can also be determined by physical analysis of the structure, such as by following these techniques: such as nuclear magnetic resonance, crystallography, electron diffraction or photoaffinity labeling, combined with the mutation of the putative key site amino acids to determine.
[0092] Table 1
[0093]
[0094]
[0095] The terms "protein", "polypeptide" and "peptide" are used interchangeably in the present invention and refer to polymers of amino acid residues, including polymers in which one or more amino acid residues are chemical analogs of natural amino acid residues. The proteins and polypeptides of the present invention can be recombinantly produced or chemically synthesized. The terms "mutant protein" or "mutant protein" refer to proteins that have substitutions, insertions, deletions and / or additions of one or more amino acid residues compared to the amino acid sequence of the parent protein. As used herein, the terms "br2 mutant protein", "mutated br2 polypeptide", "mutant br2 polypeptide", "mutant br2 protein", "mutant protein", "mutant polypeptide" and the like are used interchangeably.
[0096] The term "encoding" refers to the inherent property of a particular nucleotide sequence in a polynucleotide, such as a gene, cDNA or mRNA, to serve as a template for the synthesis of other polymers and macromolecules in a biological process having a defined nucleotide sequence (i.e., rRNA, tRNA and mRNA) or a defined amino acid sequence and the biological properties it produces. Thus, a gene encodes a protein if transcription and translation of the mRNA corresponding to the gene produces the protein in a cell or other biological system.
[0097] The term "amino acid" refers to a carboxylic acid containing an amino group. Various proteins in living organisms are composed of 20 basic amino acids.
[0098] The term "plant" is to be understood as any differentiated multicellular organism capable of photosynthesis, including crop plants at any stage of maturity or development, in particular monocotyledonous or dicotyledonous plants, vegetable crops, including artichokes, Brussels sprouts, rocket, leeks, asparagus, lettuce (e.g., head lettuce, leaf lettuce, romaine lettuce), bok choy, yellow taro, melons (e.g., melon, watermelon, Crenshaw melon, honeydew melon, cantaloupe), rapeseed crops (e.g., Brussels sprouts, cabbage, cauliflower, broccoli, kale, kale, Chinese cabbage, pak choi), cardoon, carrot, napa, okra, onion, celery, parsley, chickpeas, parsnips, endive, peppers, potatoes, cucurbits (e.g., zucchini, cucumber, courgette, squash, pumpkin), radish, cabbage, cauliflower, zucchini ... onions, rutabagas, eggplant (also called eggplant), salsify, lettuce, shallots, endive, garlic, spinach, green onions, squash, greens, beets (sugar beets and fodder beets), sweet potatoes, Swiss chard, horseradish, tomatoes, turnips, and spices; fruits and / or vines such as apples, apricots, cherries, nectarines, peaches, pears, plums, prunes, cherries, quince, almonds, chestnuts, hazelnuts, pecans, pistachios, walnuts, citrus, blueberries, boysenberries, y), cranberries, currants, loganberries, raspberries, strawberries, blackberries, grapes, avocados, bananas, kiwis, persimmons, pomegranates, pineapples, tropical fruits, pomegranates, melons, mangoes, papayas, and lychees; field crops such as clover, alfalfa, evening primrose, silver grass, corn / maize (fodder corn, sweet corn, popcorn), hops, jojoba, peanuts, rice, safflower, small grain cereals (barley, oats, rye, wheat, etc.), sorghum, tobacco, kapok, legumes (beans, lentils, peas, soybeans) , oil plants (rapeseed, mustard, poppy, olive, sunflower, coconut, castor oil plant, cocoa bean, peanut), Arabidopsis, fiber plants (cotton, flax, hemp, jute), Lauraceae (cinnamon, camphor), or a plant such as coffee, sugar cane, tea, and natural rubber plant; and / or bedding plants, such as flowering plants, cacti, succulents and / or ornamental plants, as well as trees such as forests (broadleaf trees and evergreen trees, such as conifers), fruit trees, ornamental trees, and nut-bearing trees, as well as shrubs and other seedlings.
[0099] The main advantages of the present invention are:
[0100] The present invention screens out a mutant br2 protein. Compared with wild-type corn plants, corn plants containing the mutant br2 protein have significantly lower plant height and ear height and improved lodging resistance. BRIEF DESCRIPTION OF THE DRAWINGS
[0101] Figure 1 Schematic diagram of the gene editing vector used in this embodiment.
[0102] Figure 2 Comparison of plant height and ear height between the edited plants and wild-type PH4CV corn plants.
[0103] Figure 3 Plant height of different mutant strains ( Figure 3 A) and ear height ( Figure 3 B) comparison.
[0104] Figure 4 Comparison of agronomic traits between edited plants and wild-type PH4CV plants.
[0105] Sequence Listing
[0106] SEQ ID No. describe 1 CDS sequence of br2 gene of PH4CV 2 3'UTR sequence of br2 gene of PH4CV 3 Amino acid sequence of br2 gene of PH4CV 4 Amino acid sequence of wild-type Cas12i 5 Editing the CDS sequence of the br2 gene in plants 6 Edit the 3'UTR sequence of the br2 gene in the plant DETAILED DESCRIPTION
[0107] The present invention is further described below in conjunction with the embodiments. The following description is only a preferred embodiment of the present invention, and does not limit the present invention in other forms. Any technician familiar with the profession may use the above disclosed technical content to change it into an equivalent embodiment with equivalent changes. Any simple modification or equivalent change made to the following embodiments based on the technical essence of the present invention without departing from the content of the present invention falls within the protection scope of the present invention.
[0108] Example 1. Target design and vector construction
[0109] The genomic sequence and amino acid sequence of the br2 gene were obtained through the NCBI (https: / / www.ncbi.nlm.nih.gov) website, and the target sites were selected and designed for different domain coding regions and 3'UTR sequences to obtain the br2 gene sequence of the maize inbred line PH4CV. The CDS sequence of the br2 gene of the maize inbred line PH4CV is shown in SEQ ID No.1, and the amino acid sequence is shown in SEQ ID No.3; the 3'UTR sequence of the br2 gene of the maize inbred line PH4CV is shown in SEQ ID No.2.
[0110] CDS sequence of br2 gene:
[0111] ATGTCTAGCAGCGACCCGGAGGAGATCAGGGCGCGCGTCGTCGTTCTCGGTTCGCCCC
[0112] ATGCCGACGGCGGCGACGAGTGGGCCCGGCCCGAGCTCGAGGCCTTCCATCTGCCGT
[0113] CTCCCGCCCACCAGCCTCCTGGCTTCCTAGCCGGGCAACCGGAAGCAGCAGAGCAAC
[0114] CCACGCTCCCTGCTCCTGCTGGCCGCAGCAGCAGCAGCAACACGCCTACTACATCTGG
[0115] CGGTGGCGGCGCTGCTCCTCCTCTTCCTTCTTCGCCTCCCCCTCCGCCGGCTTCTCTGG
[0116] AGACCGAGCAGCCGCCCAATGCCAGGCCAGCCTCCGCCGGCGCCAATGACAGCAAGA
[0117] AGCCCACCCCGCCCGCCGCCCTGCGCGACCTCTTCCGCTTCGCCGACGGCCTCGACTG
[0118] CGCGCTCATGCTCATCGGCACCCTCGGCGCGCTCGTCCACGGCTGCTCGCTCCCCGTC
[0119] TTCCTCCGCTTCTTCGCCGACCTCGTCGACTCCTTCGGCTCCCACGCCGACGACCCGG
[0120] ACACCATGGTCCGCCTCGTCGTCAAGTACGCCTTCTACTTCCTCGTCGTCGGAGCGGC
[0121] AATCTGGGCATCCTCGTGGGCAGAGATCTCTTGCTGGATGTGGACCGGCGAGCGGCAG
[0122] TCGACGCGGATGCGGATCCGGTACCTGGACGCGGCGCTGCGGCAGGACGTGTCCTTCT
[0123] TCGACACCGACGTGCGGGCCTCGGACGTGATCTACGCCATCAACGCGGACGCCGTGG
[0124] TGGTGCAGGACGCCATCAGCGAGAAGCTGGGCAACCTCATCCACTACATGGCCACCTT
[0125] CGTGGCCGGCTTCGTCGTGGGGTTCACGGCCGCGTGGCAGCTGGCGCTGGTCACGCT
[0126] GGCCGTGGTGCCGCTCATCGCCGTCATCGGTGGGCTGAGCGCCGCCGCGCTCGCCAAG
[0127] CTCTCGTCCCGCAGCCAGGACGCGCTCTCGGGCGCCAGCGGCATCGCGGAGCAGGCG
[0128] CTCGCGCAGATACGGATCGTGCAGGCGTTCGTCGGCGAGGAGCGCGAGATGCGGGCC
[0129] TACTCGGCGGCGCTGGCCGTGGCGCAGAGGATCGGCTACCGCAGCGGCTTCGCCAAG
[0130] GGGCTCGGCCTCGGCGGCACCTACTTCACCGTCTTCTGCTGCTACGGGCTCCTGCTCT
[0131] GGTACGGCGGCCACCTCGTGCGCGCCCAGCACACCAACGGCGGGCTCGCCATCGCCA
[0132] CCATGTTCTCCGTCATGATCGGCGGACTGGCCCTCGGGCAGTCGGCGCCGAGCATGGC
[0133] CGCGTTCGCCAAGGCGCGTGTGGCGGCTGCCAAGATCTTCCGCATCATCGACCACAGG
[0134] CCGGGCATCTCCTCGCGCGACGGCGCGGAGCCGGAGTCGGTGACGGGGCGGGTGGAG
[0135] ATGCGGGGCGTGGACTTCGCGTACCCGTCGCGGCCGGACGTCCCCATCCTGCGCGGCT
[0136] TCTCGCTGAGCGTGCCCGCCGGGAAGACCATCGCGCTGGTGGGCAGCTCCGGCTCCG
[0137] GGAAGAGCACGGTGGTGTCGCTCATCGAGAGATTCTACGACCCCAGCGCAGGGCAAA
[0138] TCCTGCTGGACGGGCACGACCTCAGGTCGCTGAAGCTGCGGTGGCTGCGGCGGCAGA
[0139] TCGGGCTGGTGAGCCAGGAGCCGGCGCTGTTCGCGACGAGCATCAGGGAGAACCTGC
[0140] TGCTGGGGCGGGACAGCCAGAGCGCGACGCTGGCGGAGATGGAGGAGGCGGCCAGG
[0141] GTGGCCAACGCCCACTCCTTCATCATCAAACTCCCCGACGGCTACGACACGCAGGTTG
[0142] GGGAGCGCGGCCTGCAGCTCTCCGGTGGCCAGAAGCAGCGCATCGCCATCGCCCGCG
[0143] CCATGCTCAAGAACCCCGCCATCCTGCTGCTGGACGAGGCCACCAGCGCGCTGGACTC
[0144] CGAGTCTGAGAAGCTCGTGCAGGAGGCGCTGGACCGCTTCATGATCGGGCGCACCAC
[0145] CCTGGTGATCGCGCACAGGCTGTCCACCATCCGCAAGGCCGACGTGGTGGCCGTGCTG
[0146] CAGGGCGGCGCCGTCTCCGAGATGGGCGCGCACGACGAGCTGATGGCCAAGGGCGAG
[0147] AACGGCACCTACGCCAAGCTCATCCGCATGCAGGAGCAGGCGCACGAGGCGGCGCTC
[0148] GTCAACGCCCGCCGCAGCAGCGCCAGGCCCTCCAGCGCCCGCAACTCCGTCAGCTCG
[0149] CCCATCATGACGCGCAACTCCTCCTACGGCCGCTCCCCCTACTCCCGCCGCCTCTCCGA
[0150] CTTCTCCACCTCCGACTTCACCCTCTCCATCCACGACCCGCACCACCACCACCGGACC
[0151] ATGGCGGACAAGCAGCTGGCGTTCCGCGCCGGCGCCAGCTCCTTCCTGCGCCTCGCCA
[0152] GGATGAACTCGCCCGAGTGGGCCTACGCGCTCGCCGGCTCCATCGGCTCCATGGTCTG
[0153] CGGCTCCTTCAGCGCCATCTTCGCCTACATCCTCAGCGCCGTGCTCAGCGTGTACTACG
[0154] CGCCGGACCCGCGGTACATGAAGCGCGAGATCGCCAAATACTGCTACCTGCTCATCGG
[0155] CATGTCCTCCGCGGCGCTGCTGTTCAACACGGTGCAGCACGTGTTCTGGGACACGGTG
[0156] GGCGAGAACCTGACCAAGCGGGTGCGCGAGAAGATGTTCGCCGCCGTGCTCCGCAAC
[0157] GAGATCGCCTGGTTCGACGCGGACGAGAACGCCAGCGCGCGCGTGGCCGCCAGGCTC
[0158] GCGCTGGACGCCCAGAACGTGCGCTCCGCCATCGGGGACCGCATCTCCGTCATCGTCC
[0159] AGAACTCGGCGCTGATGCTGGTGGCCTGCACCGCGGGGTTCGTCCTCCAGTGGCGCCT
[0160] CGCGCTCGTGCTCCTCGCCGTGTTCCCGCTCGTCGTGGGCGCCACCGTGCTGCAGAAG
[0161] ATGTTCATGAAGGGCTTCTCGGGGGACCTGGAGGCCGCGCACGCCAGGGCGACGCAG
[0162] ATCGCGGGCGAGGCCGTGGCCAACCTGCGCACCGTGGCCGCGTTCAACGCGGAGCGC
[0163] AAGATCACGGGGCTGTTCGAGGCCAACCTGCGCGGCCCGCTCCGGCGCTGCTTCTGG
[0164] AAGGGGCAGATCGCCGGCAGCGGCTACGGCGTGGCGCAGTTCCTGCTGTACGCGTCC
[0165] TACGCGCTGGGGCTGTGGTACGCGGCGTGGCTGGTGAAGCACGGCGTGTCCGACTTC
[0166] TCGCGCACCATCCGCGTGTTCATGGTGCTGATGGTGTCCGCGAACGGCGCCGCCGAGA
[0167] CGCTGACGCTGGCGCCGGACTTCATCAAGGGCGGGCGCGCGATGCGGTCGGTGTTCG
[0168] AGACGATCGACCGCAAGACGGAGGTGGAGCCCGACGACGTGGACGCGGCGCCGGTG
[0169] CCGGAGCGGCCGAGGGGCGAGGTGGAGCTGAAGCACGTGGACTTCTCGTACCCGTCG
[0170] CGGCCGGACATCCAGGTGTTCCGCGACCTGAGCCTCCGTGCGCGCGCCGGGAAGACG
[0171] CTGGCGCTGGTGGGGCCGAGCGGGTGCGGCAAGAGCTCGGTGCTGGCTCTGGTGCAG
[0172] CGGTTCTACGAGCCCACGTCCGGGCGCGTGCTCCTGGACGGCAAGGACGTGCGCAAG
[0173] TACAACCTGCGGGCGCTGCGGCGCGTGGTGGCGGTGGTGCCGCAGGAGCCGTTCCTG
[0174] TTCGCGGCGAGCATCCACGAGAACATCGCGTACGGGCGCGAGGGCGCGACGGAGGCG
[0175] GAGGTGGTGGAGGCGGCGGCGCAGGCGAACGCGCACCGGTTCATCGCGGCGCTGCCG
[0176] GAGGGGTACCGGACGCAGGTGGGCGAGCGCGGGGTGCAGCTGTCGGGAGGGCAGCG
[0177] GCAGCGGATCGCGATCGCGCGCGCGCTAGTGAAGCAGGCGGCCATCGTGCTGCTGGA
[0178] CGAGGCGACCAGCGCGCTGGACGCCGAGTCGGAGCGGTGCGTGCAGGAGGCGCTGG
[0179] AGCGCGCGGGGTCCGGGCGCACCACCATCGTGGTGGCGCACCGGCTGGCCACGGTGC
[0180] GCGGCGCGCACACCATCGCGGTCATCGACGACGGCAAGGTGGCGGAGCAGGGGTCGC
[0181] ACTCGCACCTGCTCAAGCACCATCCCGACGGGTGCTACGCGCGGATGCTGCAGCTGCA
[0182] GCGGCTGACGGGCGCGGCGGCCGGGCCCGGGCCGTCGTCCTCGTGCAACGGGGCCGCGTAG(SEQ IDNo.1);
[0183] 3'UTR sequence of br2 gene:
[0184] GACGGAATGGATGGGTTTGGTTCCTCGAGAGATTGATGGGTGAGGAAGCTGAAGCTCC
[0185] GGGATCAAATGGTGGTACTCCATGATCGCAACAATGAGGGGGAAAAAAAGAAAGGAG
[0186] AAAATACGGTGGTTCATATGATTGTACAATTTGACGATCTGTTTGAGTCGGGGTTTTAG
[0187] GATGATGTAAACCTTCACTCGCCTTTTTTTTACTCTTGTTTCTCATCCGCATCAGTATCAT
[0188] CTATCTACATACAGTGTCAGAGATGGGAACTGATCCGCATCATCATCTACCTCCCAAGG
[0189] CACCCCATATTGTATTAATGTACTTAGTTAGCCTGTTTTATATATACTTATAAGTACCAAATAGCAGAATTTTA(SEQ ID No.2);
[0190] Amino acid sequence of br2 gene:
[0191] MSSSDPEEIRARVVVLGSPHADGGDEWARPELEAFHLPSPAHQPPGFLAGQPEAAEQPTLP
[0192] APAGRSSSSNTPTTSGGGGAAPPLPSSPPPPPASLETEQPPNARPASAGANDSKKPTPPAAL
[0193] RDLFRFADGLDCALMLIGTLGALVHGCSLPVFLRFFADLVDSFGSHADDPDTMVRLVVKY
[0194] AFYFLVVGAAIWASSWAEISCWMWTGERQSTRMRIRYLDAALRQDVSFFDTDVRASDVI
[0195] YAINADAVVVQDAISEKLGNLIHYMATFVAGFVVGFTAAWQLALVTLAVVPLIAVIGGLSA
[0196] AALAKLSSRSQDALSGASGIAEQALAQIRIVQAFVVEEREMRAYSAALAVAQRIGYRSGFA
[0197] KGLGLGGTYFTVFCCYGLLLWYGGHLVRAQHTNGGLAIATMFSVMIGGLALGQSAPSM
[0198] AAFAKARVAAAKIFRIIDHRPGISSRDGAEPESVTGRVEMRGVDFAYPSRPDVPILRGFSLS
[0199] VPAGKTIALVGSSGSGKSTVVSLIERFYDPSAGQILLDGHDLRSLKLRWLRRQIGLVSQEPA
[0200] LFATSIRENLLLGRDSQSATLAEMEEAARVANAHSFIIKLPDGYDTQVGERGLQLSGGQKQ
[0201] RIAIARAMLKNPAILLLDEATSALDSESEKLVQEALDRFMIGRTTLVIAHRLSTIRKADVVA
[0202] VLQGGAVSEMGAHDELMAKGENGTYAKLIRMQEQAHEAALVNARRSSARPSSARNSVS
[0203] SPIMTRNSSYGRSPYSRRLSDFSTSDFTLSIHDPHHHHRTMADKQLAFRAGASFLRLARM
[0204] NSPEWAYALAGSIGSMVCGSFSAIFAYILSAVLSVYYAPDPRYMKREIAKYCYLLIGMSSA
[0205] ALLFNTVQHVFWDTVGENLTKRVREKMFAAVLRNEIAWFDADENASARVAARLALDAQ
[0206] NVRSAIGDRISVIVQNSALMLVACTAGFVLQWRLALVLLAVFPLVVGATVLQKMFMKGFS
[0207] GDLEAAHARATQIAGEAVANLRTVAAFNAERKITGLFEANLRGPLRRCFWKGQIAGSGYG
[0208] VAQFLLYASYALGLWYAAWLVKHGVSDFSRTIRVFMVLMVSANGAAETLTLAPDFIKGGR
[0209] AMRSVFETIDRKTEVEPDDVDAAPVPERPRGEVELKHVDFSYPSRPDIQVFRDLSLRARA
[0210] GKTLALVGPSGCGKSSVLALVQRFYEPTSGRVLLDGKDVRKYNLRALRRVVAVVPQEPFL
[0211] FAASIHENIAYGREGATEAEVVEAAAQANAHRFIAALPEGYRTQVGERGVQLSGGQRQRI
[0212] AIARALVKQAAIVLLDEATSALDAESERCVQEAALERAGSGRTTIVVAHRLATVRGAHTIAVIDDGKVAEQGSHSHLLKHHPDGCYARMLQLQRLTGAAAGPGPSSSCNGAA(SEQ IDNo.3);
[0213] In this embodiment, the Cas12i mutant protein and the sgRNA targeting the 3'UTR sequence of br2 are used to edit the 3'UTR of the br2 gene in the maize inbred line PH4CV. The specific operation method can be carried out in a conventional manner in the art. In this embodiment, the schematic diagram of the constructed gene editing vector is as follows Figure 1 As shown; among them, ZmU6 pro is U6 promoter, gly-tRNA is glycine tRNA, ZmU6 Ter For terminator, UBI pro is a UBI promoter, NLS is a nuclear localization signal, and Cas12i is a Cas12i mutant protein; in the present embodiment, the wild-type Cas12i is Cas12f.4 in CN111757889B, and the amino acid sequence is shown in SEQ ID No.4; compared with SEQ ID No.4, the Cas12i mutant protein has a mutation of S at position 7 to R, D at position 233 to R, D at position 267 to R, N at position 369 to R, and S at position 433 to R.
[0214] The amino acid sequence of wild-type Cas12i:
[0215] MKKVEVSRPYQSLLPNHRKFKYLDETWNAYKSVKSLLHRFLVCAYGAVPFNKFVEVVE
[0216] KVDNDQLVLAFAVRLFRLVPVESTSFAKVDKANLAKSLANHLPVGTAIPANVQSYFDSNF
[0217] DPKKYMWIDCAWEADRLAREMGLSASQFSEYATTMLWEDWLPLNKDDVNGWGSVSGL
[0218] FGEGKKEDRQQKVKMLNNLLNGIKKNPPKDYTQYLKILLNAFDAKSHKEAVKNYKGDS
[0219] TGRTASYLSEKSGEITELMLEQLMSNIQRDIGDKQKEISLPKKDVVKKYLESESGVPYDQN
[0220] LWSQAYRNAASSIKKTDTTRNFNSTLEKFKNEVELRGLLSEGDDVEILRSKFFSSEFHKTPD
[0221] KFVIKPEHIGFNNKYNVVAELYKLKAEATDFESAFATVKDEFEEEKGIKHPIKNILEYIWNNE
[0222] VPVEKWGRVARFNQSEEKLLRIKANPTVECNQGMTFGNSAMVGEVLRSNYVSKKGALV
[0223] SGEHGGRLIGQNNMIWLEMRLLNKKGKWETHHVPTHNMKFFEEVHAYNPSLADSVNVRN
[0224] RLYRSEDYTQLPSSITDGLKGNPCAKLLKRQHCALNNMTANVLNPKLSFTINKKNDDYTV
[0225] IIVHSVEVSKPRREVLVGDYLVGMDQNQTASNTYAVMQVVKPKSTDAIPFRNMWVRFVE
[0226] SGSIESRTLNSRGEYVDQLNHDGVDLFEIGDTEWVDSARKFFNKLGVKHKDGTLVDLSTA
[0227] PRKAYAFNNFYFKTMLNHLRSNEVDLTLLRNEILRVANGRFSPMRLGSLSWTTLKALGSF
[0228] KSLVLSYFDRLGAKEMVDKEAKDKSLFDLLVAINNKRSNKREERTSRIASSLMTVAQKYK
[0229] VDNAVVHVVVEGNLSSTDRSASKAHNRNTMDWCSRAVVKKLEDMCNLYGFNIKGVPAF
[0230] YTSHQDPLVHRADYDDPKPALRCRYSSYSRADFSKWGQNALAAVVRWASNKKSNTCYK
[0231] VGAVEFLKQHGLFADKKLTVEQFLSKVKDEEILIPRRGGRVFLTTHRLLAESTFVYLNGVKYHSCNADEVAAVNICLNDWVIPCKKKMKEESSSAG(SEQ ID No. 4);
[0232] Specifically, in this embodiment, sgRNA is designed using target Design (http: / / skl.scau.edu.cn / targetdesign / ), and the gRNA targeting the 3'UTR sequence involved is as follows:
[0233] g3'UTR-1(AGCTTCCTCACCCATCAATC);
[0234] g3'UTR-2(GACGATCTGTTTGAGTCGGG).
[0235] g3'UTR-1 and g3'UTR-2 were combined to construct vector P1515, and the two gRNAs were separated by glycine tRNA.
[0236] The specific construction method is as follows:
[0237] 1) Amplify the target fragment g3'UTR-1&2 using the primer pair, and digest the recovered fragment with BsaI;
[0238] 2) The backbone vector P0522 was digested with BsaI to recover the 23Kb fragment;
[0239] 3) Connect g3'UTR-1&2 with P0522 to construct the final vector P1515;
[0240] 4) The above ligation products were transformed into competent E. coli Trans-T1, spread on Kan plate for culture, pick 8 colonies for liquid culture for 2 hours, perform PCR bacterial liquid detection, select 2 correct monoclones, and send the bacterial liquid for testing.
[0241] 5) Select the single clone with correct sequencing for expansion, bacterial preservation, plasmid extraction, and transformation of Agrobacterium EHA105. Pick 5 single colonies for culture. After the PCR test is correct, preserve the bacteria for use.
[0242] Example 2, genetic transformation
[0243] 2.1 Transformation of Agrobacterium
[0244] The vector in Example 1 was transformed into the Agrobacterium strain EHA105 by heat shock method, and a single clone was picked out for liquid culture and PCR identification and then stored in a -80°C refrigerator for later use.
[0245] 2.2 Bacteria Activation
[0246] The bacteria were taken out from the refrigerator and streaked onto YEP solid medium.
[0247] 2.3 Preparation of Agrobacterium infection medium
[0248] Scrape fresh bacteria from the newly activated bacterial plate and resuspend them in the infection solution.
[0249] 2.4 Taking corn embryos
[0250] Take corn ears about 10 days after pollination, remove the bracts and filaments, pick out the young embryos, and put them into the infection medium (without Agrobacterium) containing AS.
[0251] 2.5 Infection
[0252] Wash the young embryos to be transformed with the infection solution three times until the infection solution is clear, pour out the infection solution and add 1 ml of bacterial solution, gently invert 10 times, and let it stand for 5 to 10 minutes. Take a clean culture dish and put 3 sterilized filter papers. After the infection is completed, invert it several times and quickly pour the bacterial solution on the filter paper. Hold the culture dish and change the direction to evenly distribute the bacterial solution carrying the young embryos on the filter paper.
[0253] 2.6 Co-culture
[0254] When the bacterial liquid can no longer be seen on the top layer of filter paper, use tweezers to pick up the upper layer of filter paper, and stick the side stained with immature embryos on the co-culture medium. Use tweezers to drive out the bubbles between the filter paper and the medium, then use tweezers to pinch a corner of the filter paper and quickly peel it off. Use an embryo peeling knife to transfer the immature embryos remaining on the filter paper to the medium, with the shield side of the immature embryo facing up, and culture in the dark at 22°C for 3 days.
[0255] 2.7 Recovery culture
[0256] After 3 days of co-culture, young embryos were transferred to recovery medium.
[0257] 2.8 Differentiation
[0258] The immature embryos transformed with P1515 vector were directly differentiated in differentiation medium.
[0259] 2.9 Rooting
[0260] Transfer the differentiated seedlings to the rooting medium, with 3 to 4 seedlings in each bottle, and culture them under light at 25 to 28°C until they grow into complete plants. After 7 days of rooting culture, small white roots will grow and can be sampled for testing.
[0261] Example 3. Screening of positive seedlings and editing of plant phenotypes
[0262] For the regenerated seedlings, a small amount of leaves were taken to extract genomic DNA using the TPS method.
[0263] For plants transformed with the vector, if the target product can be amplified by primer detection, the regenerated seedlings are transgenic positive seedlings.
[0264] For transgenic positive seedlings, primers were used to amplify the corresponding fragment of the br2 gene. The amplified product was sequenced by the Sanger method to confirm the editing form. If the sequencing result showed double peaks, the PCR product was connected to the T vector, and 5 clones were selected for sequencing to confirm the editing form.
[0265] P1515 was used to transform young embryos of PH4CV, and the 3'UTR sequence of the br2 gene of the inbred line PH4CV was edited. The edited plants were obtained, and the editing results were: the 4102-4137 bases in the CDS region of the br2 gene were deleted, the 1-36 bases and the 160-162 bases in the 3'UTR sequence were deleted; according to the amino acid structure prediction, the br2 protein was missing the 1368-1378 amino acids and extended by 45 amino acids.
[0266] Edit the CDS sequence of the plant br2 gene:
[0267] ATGTCTAGCAGCGACCCGGAGGAGATCAGGGCGCGCGTCGTCGTTCTCGGTTCGCCCC
[0268] ATGCCGACGGCGGCGACGAGTGGGCCCGGCCCGAGCTCGAGGCCTTCCATCTGCCGT
[0269] CTCCCGCCCACCAGCCTCCTGGCTTCCTAGCCGGGCAACCGGAAGCAGCAGAGCAAC
[0270] CCACGCTCCCTGCTCCTGCTGGCCGCAGCAGCAGCAGCAACACGCCTACTACATCTGG
[0271] CGGTGGCGGCGCTGCTCCTCCTCTTCCTTCTTCGCCTCCCCCTCCGCCGGCTTCTCTGG
[0272] AGACCGAGCAGCCGCCCAATGCCAGGCCAGCCTCCGCCGGCGCCAATGACAGCAAGA
[0273] AGCCCACCCCGCCCGCCGCCCTGCGCGACCTCTTCCGCTTCGCCGACGGCCTCGACTG
[0274] CGCGCTCATGCTCATCGGCACCCTCGGCGCGCTCGTCCACGGCTGCTCGCTCCCCGTC
[0275] TTCCTCCGCTTCTTCGCCGACCTCGTCGACTCCTTCGGCTCCCACGCCGACGACCCGG
[0276] ACACCATGGTCCGCCTCGTCGTCAAGTACGCCTTCTACTTCCTCGTCGTCGGAGCGGC
[0277] AATCTGGGCATCCTCGTGGGCAGAGATCTCTTGCTGGATGTGGACCGGCGAGCGGCAG
[0278] TCGACGCGGATGCGGATCCGGTACCTGGACGCGGCGCTGCGGCAGGACGTGTCCTTCT
[0279] TCGACACCGACGTGCGGGCCTCGGACGTGATCTACGCCATCAACGCGGACGCCGTGG
[0280] TGGTGCAGGACGCCATCAGCGAGAAGCTGGGCAACCTCATCCACTACATGGCCACCTT
[0281] CGTGGCCGGCTTCGTCGTGGGGTTCACGGCCGCGTGGCAGCTGGCGCTGGTCACGCT
[0282] GGCCGTGGTGCCGCTCATCGCCGTCATCGGTGGGCTGAGCGCCGCCGCGCTCGCCAAG
[0283] CTCTCGTCCCGCAGCCAGGACGCGCTCTCGGGCGCCAGCGGCATCGCGGAGCAGGCG
[0284] CTCGCGCAGATACGGATCGTGCAGGCGTTCGTCGGCGAGGAGCGCGAGATGCGGGCC
[0285] TACTCGGCGGCGCTGGCCGTGGCGCAGAGGATCGGCTACCGCAGCGGCTTCGCCAAG
[0286] GGGCTCGGCCTCGGCGGCACCTACTTCACCGTCTTCTGCTGCTACGGGCTCCTGCTCT
[0287] GGTACGGCGGCCACCTCGTGCGCGCCCAGCACACCAACGGCGGGCTCGCCATCGCCA
[0288] CCATGTTCTCCGTCATGATCGGCGGACTGGCCCTCGGGCAGTCGGCGCCGAGCATGGC
[0289] CGCGTTCGCCAAGGCGCGTGTGGCGGCTGCCAAGATCTTCCGCATCATCGACCACAGG
[0290] CCGGGCATCTCCTCGCGCGACGGCGCGGAGCCGGAGTCGGTGACGGGGCGGGTGGAG
[0291] ATGCGGGGCGTGGACTTCGCGTACCCGTCGCGGCCGGACGTCCCCATCCTGCGCGGCT
[0292] TCTCGCTGAGCGTGCCCGCCGGGAAGACCATCGCGCTGGTGGGCAGCTCCGGCTCCG
[0293] GGAAGAGCACGGTGGTGTCGCTCATCGAGAGATTCTACGACCCCAGCGCAGGGCAAA
[0294] TCCTGCTGGACGGGCACGACCTCAGGTCGCTGAAGCTGCGGTGGCTGCGGCGGCAGA
[0295] TCGGGCTGGTGAGCCAGGAGCCGGCGCTGTTCGCGACGAGCATCAGGGAGAACCTGC
[0296] TGCTGGGGCGGGACAGCCAGAGCGCGACGCTGGCGGAGATGGAGGAGGCGGCCAGG
[0297] GTGGCCAACGCCCACTCCTTCATCATCAAACTCCCCGACGGCTACGACACGCAGGTTG
[0298] GGGAGCGCGGCCTGCAGCTCTCCGGTGGCCAGAAGCAGCGCATCGCCATCGCCCGCG
[0299] CCATGCTCAAGAACCCCGCCATCCTGCTGCTGGACGAGGCCACCAGCGCGCTGGACTC
[0300] CGAGTCTGAGAAGCTCGTGCAGGAGGCGCTGGACCGCTTCATGATCGGGCGCACCAC
[0301] CCTGGTGATCGCGCACAGGCTGTCCACCATCCGCAAGGCCGACGTGGTGGCCGTGCTG
[0302] CAGGGCGGCGCCGTCTCCGAGATGGGCGCGCACGACGAGCTGATGGCCAAGGGCGAG
[0303] AACGGCACCTACGCCAAGCTCATCCGCATGCAGGAGCAGGCGCACGAGGCGGCGCTC
[0304] GTCAACGCCCGCCGCAGCAGCGCCAGGCCCTCCAGCGCCCGCAACTCCGTCAGCTCG
[0305] CCCATCATGACGCGCAACTCCTCCTACGGCCGCTCCCCCTACTCCCGCCGCCTCTCCGA
[0306] CTTCTCCACCTCCGACTTCACCCTCTCCATCCACGACCCGCACCACCACCACCGGACC
[0307] ATGGCGGACAAGCAGCTGGCGTTCCGCGCCGGCGCCAGCTCCTTCCTGCGCCTCGCCA
[0308] GGATGAACTCGCCCGAGTGGGCCTACGCGCTCGCCGGCTCCATCGGCTCCATGGTCTG
[0309] CGGCTCCTTCAGCGCCATCTTCGCCTACATCCTCAGCGCCGTGCTCAGCGTGTACTACG
[0310] CGCCGGACCCGCGGTACATGAAGCGCGAGATCGCCAAATACTGCTACCTGCTCATCGG
[0311] CATGTCCTCCGCGGCGCTGCTGTTCAACACGGTGCAGCACGTGTTCTGGGACACGGTG
[0312] GGCGAGAACCTGACCAAGCGGGTGCGCGAGAAGATGTTCGCCGCCGTGCTCCGCAAC
[0313] GAGATCGCCTGGTTCGACGCGGACGAGAACGCCAGCGCGCGCGTGGCCGCCAGGCTC
[0314] GCGCTGGACGCCCAGAACGTGCGCTCCGCCATCGGGGACCGCATCTCCGTCATCGTCC
[0315] AGAACTCGGCGCTGATGCTGGTGGCCTGCACCGCGGGGTTCGTCCTCCAGTGGCGCCT
[0316] CGCGCTCGTGCTCCTCGCCGTGTTCCCGCTCGTCGTGGGCGCCACCGTGCTGCAGAAG
[0317] ATGTTCATGAAGGGCTTCTCGGGGGACCTGGAGGCCGCGCACGCCAGGGCGACGCAG
[0318] ATCGCGGGCGAGGCCGTGGCCAACCTGCGCACCGTGGCCGCGTTCAACGCGGAGCGC
[0319] AAGATCACGGGGCTGTTCGAGGCCAACCTGCGCGGCCCGCTCCGGCGCTGCTTCTGG
[0320] AAGGGGCAGATCGCCGGCAGCGGCTACGGCGTGGCGCAGTTCCTGCTGTACGCGTCC
[0321] TACGCGCTGGGGCTGTGGTACGCGGCGTGGCTGGTGAAGCACGGCGTGTCCGACTTC
[0322] TCGCGCACCATCCGCGTGTTCATGGTGCTGATGGTGTCCGCGAACGGCGCCGCCGAGA
[0323] CGCTGACGCTGGCGCCGGACTTCATCAAGGGCGGGCGCGCGATGCGGTCGGTGTTCG
[0324] AGACGATCGACCGCAAGACGGAGGTGGAGCCCGACGACGTGGACGCGGCGCCGGTG
[0325] CCGGAGCGGCCGAGGGGCGAGGTGGAGCTGAAGCACGTGGACTTCTCGTACCCGTCG
[0326] CGGCCGGACATCCAGGTGTTCCGCGACCTGAGCCTCCGTGCGCGCGCCGGGAAGACG
[0327] CTGGCGCTGGTGGGGCCGAGCGGGTGCGGCAAGAGCTCGGTGCTGGCTCTGGTGCAG
[0328] CGGTTCTACGAGCCCACGTCCGGGCGCGTGCTCCTGGACGGCAAGGACGTGCGCAAG
[0329] TACAACCTGCGGGCGCTGCGGCGCGTGGTGGCGGTGGTGCCGCAGGAGCCGTTCCTG
[0330] TTCGCGGCGAGCATCCACGAGAACATCGCGTACGGGCGCGAGGGCGCGACGGAGGCG
[0331] GAGGTGGTGGAGGCGGCGGCGCAGGCGAACGCGCACCGGTTCATCGCGGCGCTGCCG
[0332] GAGGGGTACCGGACGCAGGTGGGCGAGCGCGGGGTGCAGCTGTCGGGAGGGCAGCG
[0333] GCAGCGGATCGCGATCGCGCGCGCGCTAGTGAAGCAGGCGGCCATCGTGCTGCTGGA
[0334] CGAGGCGACCAGCGCGCTGGACGCCGAGTCGGAGCGGTGCGTGCAGGAGGCGCTGG
[0335] AGCGCGCGGGGTCCGGGCGCACCACCATCGTGGTGGCGCACCGGCTGGCCACGGTGC
[0336] GCGGCGCGCACACCATCGCGGTCATCGACGACGGCAAGGTGGCGGAGCAGGGGTCGC
[0337] ACTCGCACCTGCTCAAGCACCATCCCGACGGGTGCTACGCGCGGATGCTGCAGCTGCAGCGGCTGACGGGCGCGGCGGCCGGG(SEQ ID No.5);
[0338] Editing the 3'UTR sequence of the br2 gene in the plant:
[0339] TGGGTGAGGAAGCTGAAGCTCCGGGATCAAATGGTGGTACTCCATGATCGCAACAATG
[0340] AGGGGGAAAAAAAGAAAGGAGAAAATACGGTGGTTCATATGATTGTACAATTTGACG
[0341] ATCTGTTTTCGGGGTTTTAGGATGATGTAAAACCTTCACTCGCCTTTTTTTTACTCTTGTT
[0342] TCTCATCCGCATCAGTATCATCTATCTACATACAGTGTCAGAGATGGGAACTGATCCGC
[0343] ATCATCATCTACCTCCCAAGGCACCCCATATTGTATTAATGTACTTAGTTAGCCTGTTTTATATATACTTATAAGTACCAAATAGCAGAATTTTA (SEQ ID No. 6);
[0344] Compared with wild-type PH4CV plants, the plant height of the edited plants decreased by about 20%, and the ear height decreased by about 30%. Figure 2 shown.
[0345] Statistics of the dwarfing phenotypes of strains with different mutation types of the br2 gene show that the plant height of most strains with mutations in the CDS region of the br2 gene is reduced by more than 30%, and the ear height is reduced by more than 55%; the plant height of most strains with mutations in the 3'UTR sequence of the br2 gene is reduced by less than 10%, and the ear height is not significantly reduced. It can be seen that compared with the dwarfing phenotype (plant height and ear height) of the mutant strains in the CDS region of the br2 gene, the dwarfing phenotype of this edited plant is milder; compared with the dwarfing phenotype (plant height and ear height) of the mutant strains in the 3'UTR sequence of the br2 gene, the dwarfing phenotype of this edited plant is more obvious, such as Figure 3 As shown ( Figure 3 A is the comparison of plant heights of strains with different mutation types. Figure 3 A is the comparison of ear height of each mutation type).
[0346] The stem strength tester YYD-1B of Zhejiang Top Yunnong Technology Co., Ltd. was used to measure the stem strength of wild-type PH4CV plants and edited plants: 15 plants of each pollinated line were selected, the stems were fixed together with rubber strips and instruments, and placed 20 cm above the ground. The corn stalks were pushed at right angles until the stalks formed a 45-degree angle with the ground, and the values were recorded in Newtons (N). This value is the bending resistance, which represents the stem strength. The greater the stem strength, the stronger the plant's ability to resist lodging and bending.
[0347] Edit the agronomic traits of the plant such as Figure 4 As shown. Figure 4 In AK, PH4CV refers to the wild-type PH4CV plant, and ko refers to the edited plant. Compared with the wild-type PH4CV, the plant height was reduced by 20% ( Figure 4 A), ear height decreased by 31% ( Figure 4 B); the stem strength increased significantly ( Figure 4 C), the ability to resist lodging and bending is enhanced; the leaf width becomes larger ( Figure 4 D) and the leaf length becomes shorter ( Figure 4 E), row number ( Figure 4 F) and ear row number ( Figure 4 G) had no significant difference, spike length ( Figure 4 H and Figure 4 J) was slightly shorter but there was no significant difference. The ear diameter ( Figure 4 I) slightly increased but without significant difference, grain width and grain length ( Figure 4 K) also showed no significant difference. This indicates that the edited plants not only have reduced plant height and ear height, but also have enhanced lodging resistance, and have the potential to resist lodging and increase yield under high-density planting conditions.
[0348] All documents mentioned in the present invention are cited as references in this application, just as each document is cited as reference individually. In addition, it should be understood that after reading the above teachings of the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms also fall within the scope defined by the claims attached to this application.
Claims
1. A br2 mutant protein, characterized in that The CDS sequence and 3'UTR sequence of the mutant br2 protein have base deletions relative to the CDS sequence and 3'UTR sequence of the parent br2 protein; The parent br2 protein is derived from corn; the mutant br2 protein causes the plant height and / or ear height of corn to be reduced, the lodging resistance to be improved, the yield to be increased, or the yield to be increased under high-density planting conditions.
2. The mutant protein according to claim 1, characterized in that The CDS sequence of the mutant br2 protein lacks bases 4102-4137 corresponding to the sequence shown in SEQ ID No. 1 relative to the CDS sequence of the parent br2 protein; the 3'UTR sequence of the mutant br2 protein lacks bases 1-36 and bases 160-162 corresponding to the sequence shown in SEQ ID No. 2 relative to the 3'UTR sequence of the parent br2 protein; Preferably, the CDS sequence of the parent br2 protein is shown as SEQ ID No.1, and the 3'UTR sequence of the parent br2 protein is shown as SEQ ID No.
2.
3. A polynucleotide encoding the br2 mutant protein according to any one of claims 1-2. A vector comprising the polynucleotide according to claim 3.
5. A host cell comprising the br2 mutant protein according to any one of claims 1-2, or the polynucleotide according to claim 3, or the vector according to claim 4.
6. A gene editing reagent, characterized in that: The gene editing reagent can produce the mutant protein described in any one of claims 1-2 in a plant; the gene editing reagent includes CRISPR / Cas protein and gRNA, the gRNA can target the 3'UTR sequence of the plant endogenous br2 protein, and the plant is corn.
7. A method for improving plant traits, the method comprising the step of introducing the br2 mutant protein according to any one of claims 1 to 2 into plant cells, plant seeds, plant tissues, plant parts or plants, wherein the plant is corn; Preferably, the improved plant traits include reducing plant height and / or ear height, improving plant lodging resistance, increasing plant yield, or increasing plant yield under high-density planting conditions.
8. The method according to claim 7, characterized in that The introduction of the br2 mutant protein according to any one of claims 1-2 comprises the step of mutating the CDS sequence and 3'UTR sequence of the endogenous br2 protein of the plant to introduce the mutant protein; preferably, the br2 mutant protein is introduced into the plant by gene editing.
9. The method according to claim 7, characterized in that: The introduction of the br2 mutant protein according to any one of claims 1-2 comprises the step of expressing the mutant protein in plant cells, plant seeds, plant tissues, plant parts or plants.
10. Use of the mutant protein according to any one of claims 1-2, the polynucleotide according to claim 3, the vector according to claim 4, the host cell according to claim 5, or the gene editing reagent according to claim 6 in preparing plants with reduced plant height and / or ear height, improved lodging resistance, increased yield, or increased yield under high-density planting conditions; or, use of the mutant protein according to any one of claims 1-2, the polynucleotide according to claim 3, the vector according to claim 4, the host cell according to claim 5, or the gene editing reagent according to claim 6 in preparing plants with reduced plant height and / or ear height, improved lodging resistance, increased plant yield, or increased yield under high-density planting conditions; the plant is corn.
